Mepolizumab effectiveness for patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps in Italy (MEPOREAL): a real-life, multicentre, phase 4 trial.

De Corso E, Ottaviano G, Seccia V, Pipolo C, Canevari FRM, Maggiore G, Cantone E, Pagella F, Anastasi F, Pasquini E, Torretta S, Garzaro M, Gallo S, Loperfido A, D'Ascanio L, Moffa A, Cavaliere C, Caruso M, Anzivino R, Fadda G, Passali FM, Iannuzzi L, Urbanelli A, Tomacelli GL, Poma S, Corbò M, Montuori C, D'Auria LM, Galli J, La Mantia I, ENT Biologic Italian study group (PolyData Forum)

Open source

DOI: 10.1016/s2213-2600(26)00197-9
Published: 2026 Aug 18
Container: The Lancet. Respiratory medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2213-2600-26-00197-9,
  title = {Mepolizumab effectiveness for patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps in Italy (MEPOREAL): a real-life, multicentre, phase 4 trial.},
  author = {De Corso E and Ottaviano G and Seccia V and Pipolo C and Canevari FRM and Maggiore G and Cantone E and Pagella F and Anastasi F and Pasquini E and Torretta S and Garzaro M and Gallo S and Loperfido A and D'Ascanio L and Moffa A and Cavaliere C and Caruso M and Anzivino R and Fadda G and Passali FM and Iannuzzi L and Urbanelli A and Tomacelli GL and Poma S and Corbò M and Montuori C and D'Auria LM and Galli J and La Mantia I and ENT Biologic Italian study group (PolyData Forum)},
  year = {2026},
  journal = {The Lancet. Respiratory medicine},
  doi = {10.1016/s2213-2600(26)00197-9},
  url = {https://doi.org/10.1016/s2213-2600(26)00197-9}
}

RIS

TY  - JOUR
TI  - Mepolizumab effectiveness for patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps in Italy (MEPOREAL): a real-life, multicentre, phase 4 trial.
AU  - De Corso E
AU  - Ottaviano G
AU  - Seccia V
AU  - Pipolo C
AU  - Canevari FRM
AU  - Maggiore G
AU  - Cantone E
AU  - Pagella F
AU  - Anastasi F
AU  - Pasquini E
AU  - Torretta S
AU  - Garzaro M
AU  - Gallo S
AU  - Loperfido A
AU  - D'Ascanio L
AU  - Moffa A
AU  - Cavaliere C
AU  - Caruso M
AU  - Anzivino R
AU  - Fadda G
AU  - Passali FM
AU  - Iannuzzi L
AU  - Urbanelli A
AU  - Tomacelli GL
AU  - Poma S
AU  - Corbò M
AU  - Montuori C
AU  - D'Auria LM
AU  - Galli J
AU  - La Mantia I
AU  - ENT Biologic Italian study group (PolyData Forum)
PY  - 2026
JO  - The Lancet. Respiratory medicine
DO  - 10.1016/s2213-2600(26)00197-9
UR  - https://doi.org/10.1016/s2213-2600(26)00197-9
ER  -

APA

E, D. C., G, O., V, S., C, P., FRM, C., G, M., E, C., F, P., F, A., E, P., S, T., M, G., S, G., A, L., L, D., A, M., C, C., M, C., R, A., G, F., FM, P., L, I., A, U., GL, T., S, P., M, C., C, M., LM, D., J, G., I, L. M., & Forum), E. B. I. S. G. (. (2026). Mepolizumab effectiveness for patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps in Italy (MEPOREAL): a real-life, multicentre, phase 4 trial.. The Lancet. Respiratory medicine. https://doi.org/10.1016/s2213-2600(26)00197-9

Source records

pubmed · retrieved 2026-09-26T23:09:30.588Z